Matthew L. Posard Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew L. Posard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew L. Posard. Matthew L. Posard is Sr VP & General Manager in ILLUMINA INC ($ILMN) and Sr VP & GM, Consumer Genomics in ILLUMINA INC ($ILMN) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and Chief Commercial Officer in Trovagene, Inc. ($XNOM.OB) and Director in Talis Biomedical Corp ($TLIS) and Director in DermTech, Inc. ($DMTK).
Latest Insider Trading Transactions of Matthew L. Posard
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XNOM.OB, DMTK, GYHT, ILMN, TLIS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 06 2021 | GYHT | HALOZYME THERAPEUT ... | Posard Matthew L. | Director | Grant | A | 0.00 | 5,230 | 0 | 128,983 | 123.8 K to 129 K (+4.23 %) |
Feb 19 2021 | TLIS | Talis Biomedical C ... | Posard Matthew L. | Director | Buy | P | 16.00 | 62,500 | 1,000,000 | 62,500 | 0 to 62.5 K |
Jan 13 2021 | DMTK | DermTech, Inc. | Posard Matthew L. | Director | Buy | P | 29.50 | 33,898 | 999,991 | 86,863 | 53 K to 86.9 K (+64.00 %) |
Jun 19 2020 | DMTK | DermTech, Inc. | Posard Matthew L. | Director | Grant | A | 0.00 | 8,000 | 0 | 52,965 | 45 K to 53 K (+17.79 %) |
May 01 2020 | GYHT | HALOZYME THERAPEUT ... | Posard Matthew L. | Director | Grant | A | 0.00 | 8,829 | 0 | 123,753 | 114.9 K to 123.8 K (+7.68 %) |
May 01 2020 | DMTK | DermTech, Inc. | Posard Matthew L. | Director | Option Exercise | M | 6.94 | 9,702 | 67,332 | 0 | |
May 01 2020 | DMTK | DermTech, Inc. | Posard Matthew L. | Director | Buy | M | 6.94 | 9,702 | 67,332 | 44,965 | 35.3 K to 45 K (+27.51 %) |
May 03 2019 | GYHT | HALOZYME THERAPEUT ... | Posard Matthew L. | Director | Grant | A | 0.00 | 12,173 | 0 | 114,924 | 102.8 K to 114.9 K (+11.85 %) |
May 02 2018 | GYHT | HALOZYME THERAPEUT ... | Posard Matthew L. | Director | Grant | A | 0.00 | 10,363 | 0 | 102,751 | 92.4 K to 102.8 K (+11.22 %) |
May 05 2017 | GYHT | HALOZYME THERAPEUT ... | Posard Matthew L. | Director | Grant | A | 0.00 | 14,135 | 0 | 92,388 | 78.3 K to 92.4 K (+18.06 %) |
May 06 2016 | GYHT | HALOZYME THERAPEUT ... | Posard Matthew L. | Director | Grant | A | 0.00 | 20,202 | 0 | 78,253 | 58.1 K to 78.3 K (+34.80 %) |
Jan 06 2016 | XNOM.OB | Trovagene, Inc. | Posard Matthew L. | Chief Commercial Of ... | Option Exercise | A | 5.18 | 150,000 | 777,000 | 650,000 | |
May 07 2015 | GYHT | HALOZYME THERAPEUT ... | Posard Matthew L. | Director | Grant | A | 0.00 | 13,175 | 0 | 58,051 | 44.9 K to 58.1 K (+29.36 %) |
May 30 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Option Exercise | M | 37.04 | 2,836 | 105,045 | 7,563 | |
May 30 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Sell | S | 70.80 | 2,836 | 200,789 | 30,858 | 33.7 K to 30.9 K (-8.42 %) |
May 30 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Buy | M | 37.04 | 2,836 | 105,045 | 33,694 | 30.9 K to 33.7 K (+9.19 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Option Exercise | M | 37.04 | 17,016 | 630,273 | 10,399 | |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Option Exercise | M | 32.49 | 5,032 | 163,465 | 0 | |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Option Exercise | M | 28.45 | 17,850 | 507,833 | 0 | |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Option Exercise | M | 20.04 | 8,334 | 167,013 | 0 | |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Sell | S | 57.95 | 11,550 | 669,323 | 30,858 | 42.4 K to 30.9 K (-27.24 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Buy | M | 28.45 | 11,550 | 328,598 | 42,408 | 30.9 K to 42.4 K (+37.43 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Sell | S | 57.95 | 4,200 | 243,390 | 30,858 | 35.1 K to 30.9 K (-11.98 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Buy | M | 28.45 | 4,200 | 119,490 | 35,058 | 30.9 K to 35.1 K (+13.61 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Sell | S | 57.95 | 2,100 | 121,695 | 30,858 | 33 K to 30.9 K (-6.37 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Buy | M | 28.45 | 2,100 | 59,745 | 32,958 | 30.9 K to 33 K (+6.81 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Sell | S | 57.95 | 8,334 | 482,955 | 30,858 | 39.2 K to 30.9 K (-21.26 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Buy | M | 20.04 | 8,334 | 167,013 | 39,192 | 30.9 K to 39.2 K (+27.01 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Sell | S | 57.95 | 5,032 | 291,604 | 30,858 | 35.9 K to 30.9 K (-14.02 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Buy | M | 32.49 | 5,032 | 163,465 | 35,890 | 30.9 K to 35.9 K (+16.31 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Sell | S | 57.95 | 2,836 | 164,346 | 30,858 | 33.7 K to 30.9 K (-8.42 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Buy | M | 37.04 | 2,836 | 105,045 | 33,694 | 30.9 K to 33.7 K (+9.19 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Sell | S | 57.95 | 10,399 | 602,622 | 30,858 | 41.3 K to 30.9 K (-25.21 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Buy | M | 37.04 | 10,399 | 385,179 | 41,257 | 30.9 K to 41.3 K (+33.70 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Sell | S | 57.95 | 3,781 | 219,109 | 30,858 | 34.6 K to 30.9 K (-10.92 %) |
Apr 15 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Buy | M | 37.04 | 3,781 | 140,048 | 34,639 | 30.9 K to 34.6 K (+12.25 %) |
Mar 12 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Payment of Exercise | F | 53.77 | 939 | 50,490 | 30,858 | 31.8 K to 30.9 K (-2.95 %) |
Mar 12 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Payment of Exercise | F | 53.77 | 685 | 36,832 | 31,797 | 32.5 K to 31.8 K (-2.11 %) |
Jan 31 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Option Exercise | A | 0.00 | 20,063 | 0 | 20,063 | |
Jan 31 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Payment of Exercise | F | 50.63 | 300 | 15,189 | 31,867 | 32.2 K to 31.9 K (-0.93 %) |
Jan 31 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Grant | A | 0.00 | 4,458 | 0 | 32,167 | 27.7 K to 32.2 K (+16.09 %) |
Jan 29 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Payment of Exercise | F | 51.62 | 728 | 37,579 | 27,709 | 28.4 K to 27.7 K (-2.56 %) |
Jan 29 2013 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & General Man ... | Payment of Exercise | F | 51.62 | 662 | 34,172 | 28,437 | 29.1 K to 28.4 K (-2.27 %) |
Mar 12 2012 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & GM, Consume ... | Option Exercise | A | 0.00 | 32,813 | 0 | 32,813 | |
Mar 12 2012 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & GM, Consume ... | Grant | A | 0.00 | 7,292 | 0 | 29,099 | 21.8 K to 29.1 K (+33.44 %) |
Mar 12 2012 | ILMN | ILLUMINA INC | Posard Matthew L. | Sr VP & GM, Consume ... | Grant | A | 0.00 | 5,000 | 0 | 21,807 | 16.8 K to 21.8 K (+29.75 %) |
Page: 1